Steve Scala analyst TD COWEN

Currently, out of the existing stock ratings of Steve Scala - 28 which are a Hold (34.57%), 50 which are a Buy (61.73%), 3 which are a Sell (3.7%)

Steve Scala

Work Performance Price Targets & Ratings Chart

Analyst Steve Scala works at TD COWEN and is covering the Healthcare sector with 163 price targets and ratings displayed on 13 stocks.

Steve Scala's average stock forecast success ratio is 76.43% with an average time for price targets to be met of 673.17 days.

Most recent stock forecast was given on BMY, BristolMyers Squibb Company at 15-Sep-2023.

Wall Street Analyst Steve Scala

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for PFE (PFIZER) at 11/5/2021. The price target of $56 was fulfilled within 40 days with a profit of $9.35 (20.04%) receiving and performance score of 5.01.

Average potential price target upside

ABBV AbbVie AZN AstraZeneca PLC BMY BristolMyers Squibb Company ELAN Elanco Animal Health GSK GlaxoSmithKline plc LLY Eli Lilly and Company MRK Merck . NVS Novartis AG PFE Pfizer EQRX ZTS Zoetis NVO RHHBY

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

177

$27.94 (18.74%)

167

1 days ago

10/14 (71.43%)

$17.75 (15.37%)

122

Buy

170

$20.94 (14.05%)

163

2 months 2 days ago

33/34 (97.06%)

$24.97 (28.96%)

433

Buy

182

$32.94 (22.10%)

181

2 months 19 days ago

6/15 (40%)

$28.98 (32.96%)

467

Buy

155

5 months 25 days ago

1/1 (100%)

$21 (15.67%)

90

Buy

172

$22.94 (15.39%)

166

6 months 29 days ago

23/24 (95.83%)

$22.65 (31.91%)

519

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Steve Scala is most bullish on?

Potential upside of $7.96 has been obtained for BMY (BRISTOLMYERS SQUIBB COMPANY)

Which stock is Steve Scala is most reserved on?

Potential downside of -$37.13 has been obtained for LLY (ELI LILLY AND COMPANY)

What Year was the first public recommendation made by Steve Scala?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart